Treatment of impetigo: Paint it blue

BMJ

Volumn 329, Issue 7472, 2004, Pages 979-

  Macdonald, Roderic S ^a  

^a NONE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CRYSTAL VIOLET; TOPICAL ANTIINFECTIVE AGENT; ANTIBIOTIC AGENT; DISINFECTANT AGENT; FUSIDIC ACID; PSEUDOMONIC ACID; SOAP; WATER;

HUMAN; IMPETIGO; NOTE; PENICILLIN RESISTANCE; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; BONE INFECTION; CLINICAL TRIAL; DRUG EFFICACY; EXPERIENCE; GENERAL PRACTITIONER; HEALTH CARE POLICY; HEALTH SURVEY; LETTER; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PRACTICE GUIDELINE; PRIORITY JOURNAL; SWEDEN;

ANTI-INFECTIVE AGENTS, LOCAL; GENTIAN VIOLET; HUMANS; IMPETIGO; METHICILLIN RESISTANCE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 6944245337     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.329.7472.979     Document Type: Letter

References (3)

1. Koning S, van der Wouden JC. Treatment for impetigo. BMJ 2004; 329: 695–6. (25 September.)
2. Okano M, Noguchi S, Tabata K, Matsumoto Y. Topical gentian violet for cutaneous infections and nasal carriers with MRSA. Int J Dermatol 2000; 39: 942–4.
3. Parker WT, Binder PS. Gentian violet: keratoconjunctivitis. Am J Ophthalmol 1979; 87: 340–3.